The first G1 Therapeutics trade was made in Q2 2021.
Since then Ken Fisher bought shares four more times and sold shares on five occasions. The investor completely sold their stake between Q4 2022 and Q3 2023.
Avg closing price
Price range
Sold -2.54 Million shares
Q3 2023
Avg closing price
$1.94
Price range
$1.22
-
$2.67
Sold 6.6% shares (-181 Thousand shares)
Q2 2023
Avg closing price
$2.73
Price range
$2.46
-
$3.14
Sold 3.0% shares (-85.5 Thousand shares)
Q1 2023
Avg closing price
$4.80
Price range
$2.57
-
$8.16
Sold 4.3% shares (-126 Thousand shares)
Q4 2022
Avg closing price
$8.38
Price range
$5.19
-
$13.50
Increased shares by 27.2% (+627 Thousand shares)
Q3 2022
Avg closing price
$11.42
Price range
$5.17
-
$16.99
Sold 0.1% shares (-2.58 Thousand shares)
Q2 2022
Avg closing price
$5.54
Price range
$4.04
-
$8.51
Increased shares by 1.9% (+43.1 Thousand shares)
Q1 2022
Avg closing price
$9.48
Price range
$7.60
-
$11.02
Increased shares by 30.5% (+530 Thousand shares)
Q4 2021
Avg closing price
$12.74
Price range
$10.16
-
$16.17
Increased shares by 90.0% (+823 Thousand shares)
Q3 2021